Vanguard Group’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,483,472
| Closed | -$633K | – | 4626 |
|
|
2023
Q1 | $633K | Buy |
2,483,472
+712,450
| +40% | +$182K | ﹤0.01% | 4052 |
|
|
2022
Q4 | $2.09M | Sell |
1,771,022
-1,455,445
| -45% | -$1.72M | ﹤0.01% | 3638 |
|
|
2022
Q3 | $6.58M | Buy |
3,226,467
+2,161,758
| +203% | +$4.41M | ﹤0.01% | 3167 |
|
|
2022
Q2 | $1.64M | Buy |
1,064,709
+19,266
| +2% | +$29.7K | ﹤0.01% | 3893 |
|
|
2022
Q1 | $5.28M | Buy |
1,045,443
+422,804
| +68% | +$2.14M | ﹤0.01% | 3502 |
|
|
2021
Q4 | $3.86M | Buy |
+622,639
| New | +$3.86M | ﹤0.01% | 3754 |
|